PREMIUM IMMUNE CELLS FOR CELL & GENE THERAPY RESEARCH AND DEVELOPMENT

GETTING CELL & GENE THERAPIES TO MARKET FASTER WITH CUSTOM SOLUTIONS

The field of cell & gene therapy continues to hold remarkable promise for the treatment of cancer and other chronic conditions. With more than 30 years of biospecimen collection, BioIVT is ready to be your preferred provider for immune cell products. Whether you’re developing a cell or gene therapy or the manufacturing platforms to support it – we’ll work with you to ensure you get the cells you need when you need them.

THE RIGHT STARTING MATERIAL FOR YOUR CELL AND GENE THERAPY RESEARCH

With cell & gene therapies, the process is the product – so ensuring high-quality starting material is a critical first step in maximizing your results. BioIVT has over 35 years of experience in biospecimen procurement to bring you the best products for your research. Our diverse donor pool consists of over 600 recallable, consented donors around the globe. All products are collected using strict IRB protocols at strategically located facilities under FDA and HTA guidelines. 

Choose from any of the following immune cell products:

Leukopak_Icon

LEUKOMAX® Leukopaks

Normal LEUKOMAX Leukopaks and  
Normal Mobilized LEUKOMAX Leukopaks

View Options

For our collection process and cancellation policies, see our Leukapheresis Collections Page.
Mononuclear Cells_Icon

Mononuclear
Cells

Mononuclear Cells, from Peripheral Blood (PBMC), Bone Marrow (BMMC) and Cord Blood (CBMC)

View Inventory

Cell Subsets_Icon

Purified Immune Cell Subsets

Purified Immune Cell Subsets, isolated from  Peripheral Blood, Bone Marrow and Cord Blood

View Inventory

 

Look to BioIVT for expertise in the processes required for the ethical acquisition of biospecimens
and the protocols needed for the production of reliable data.

IMMUNE CELLS YOU NEED … JUST A CLICK AWAY!

Browse Our Digital Portal
GMP Leuk_Serum

GMP MANUFACTURING WITH VIVOSTART™

With cell & gene therapies, the process is the product – so ensuring high-quality starting material is a critical first step in maximizing your results. BioIVT’s new line of VivoSTART GMP-compliant Leukopaks and Plasma-derived/Off-the-clot Human AB Serum can seamlessly integrate into your workflow.

  • Collections performed in an FDA-registered, GMP-compliant center that meets 21 CFR 1271 specifications
  • Batch record documentation in compliance with FDA and HTA requirements

Maximize your GMP immune cell expansion with VivoSTART Human AB Serum to reach therapeutic doses faster.

GMP Manufacturing

THE RIGHT MATERIAL FOR YOUR CELL AND GENE THERAPY RESEARCH

BioIVT has over 35 years of experience in biospecimen procurement to bring you the best products for your research. Our diverse donor pool consists of over 600 recallable, consented donors around the globe. All products are collected using strict IRB protocols at strategically located facilities under FDA and HTA guidelines.

Choose from any of the following immune cell products:

Look to BioIVT for expertise in the processes required for the ethical acquisition of biospecimens and the protocols needed for the production of reliable data.

Disease Immune Cellls

GET CLOSER TO REAL-WORLD CONDITIONS WITH DISEASE STATE IMMUNE CELLS

The development of manufacturing processes for therapies – as well as the testing of ancillary equipment, consumables, media, and reagents – can use starting materials sourced from patients with diseases to ensure their fit for purpose in autologous therapy or other research applications.

Choose from any of the following disease states:
  • Oncology – including ALL, CLL, DLBCL, MM, solid tumors, and more
    • PBMCs and limited LEUKOMAX Leukopaks available
  • Autoimmune/Inflammatory – including SLE, RA, Crohn’s, and more
    • PBMCs and Half/Quarter LEUKOMAX Leukopaks available
  • Infectious Disease – including HBV, HCV, HIV, and more
    • PBMCs and Half/Quarter LEUKOMAX Leukopaks available
Cell Characterization

HIGH-DEFINITION CHARACTERIZATION TO GET THE MOST OUT OF YOUR CELLS

As regulatory agencies across the globe update their approval criteria for cell & gene therapies, data becomes key – both upstream and downstream. Get the most out of your cells with detailed testing at the forefront of industry standards.

Our standard high-resolution characterization capabilities include:
  • HLA-typing – 6-digit typing on HLA-A-c, DPA & DPB, DQA & DQB, and DRB
  • Fc-receptor genotyping – integral part of the antibody-dependent cellular cytotoxicity (ADCC) pathway
  • CMV serology status – a common opportunistic pathogen, cytomegalovirus infection can impact subsequent immune responses
Looking for other immune cell testing services? BioIVT will work with you to customize your cell’s characterization level.
Featured Resources

Get the product information you need for your research with our technical content. Click here to learn more about our solutions for cell and gene therapy research with our suite of white papers,
videos, blogs and more.

ATMP Quality by Design Webinar

[WEBINAR] Critical Considerations When Sourcing Cellular Starting Materials & Ancillary Products for CGT

Hear important considerations when sourcing starting materials that must be factored into your program to efficiently move through the clinical pipeline and successfully receive regulatory approval in this expert panel discussion.
 
Disease State Cells WP

[WHITE PAPER] Disease State Primary Cells Bring Verification and Validation Studies Closer to Real-World Results

Discover how the verification and validation study applications for oncology, autoimmune, inflammatory, and infectious disease state PBMCs and LEUKOMAX leukopaks to bring researchers closer to real-world results.
 
Human AB Fast Facts Video

[VIDEO] Cell & Gene Therapy Insights Fastfacts: Getting Closer to The In Vivo Environment With Human Ab Serum

Discover how the verification and validation study applications for oncology, autoimmune, inflammatory, and infectious disease state PBMCs and LEUKOMAX leukopaks to bring researchers closer to real-world results.
Leuko Protocol

[PROTOCOL] Thawing Cryopreserved LEUKOMAX Leukopaks

Protocol detailing the thawing of cryopreserved LEUKOMAX leukopak to improve post-thaw cell viability.

 
Immunology Brochure

[BROCHURE] Immunology & Immune Cell Products


Download our brochure to learn more about our portfolio of immune cell products has your cell & gene therapy, regenerative medicine, or immunotherapy research needs covered.  
 
 
Immune Cell Publications

[COMPENDIUM] Selected Immune Cell Publications


BioIVT's Immune Cell Subsets and Leukopaks have incredible utility in many different research applications. See how they've helped researchers like you!